Clinical Trial Update: Study to Evaluate the Safety and Efficacy of ARI0002h, for the Initial Treatment of Patients With Primary Plasma Cell Leukaemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating ARI0002h for initial treatment of primary plasma cell leukemia; the study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasma Cell Leukemia

Drugs mentioned

• ARI0002h

Snippet

Sponsor: Fundacion Clinic per a la Recerca Biomédica | Conditions: Leukemia, Plasma Cell | Phase 2 | Status: NOT_YET_RECRUITING